The short version of pentadecapeptide fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-02-27 and is reviewed periodically as new material appears.
Direct human evidence is scarce. One trial in ulcerative colitis delivered the compound by enema and produced limited publicly reported results without a clear benefit. The compound is not an approved medicine in most jurisdictions. In many markets it is sold as a research chemical; in others it falls under prescription or controlled categories. Regulators have not confirmed any claimed medical use, and product labels rarely undergo premarket review.
Most published reports describe experiments in rodents rather than in people. These studies examine outcomes in tendons, ligaments, bone, stomach lining, and intestinal tissue. In rat and mouse models, a frequently reported effect is faster healing or reduced damage. Sample sizes are usually small, and a substantial share of the work originates from a small number of research groups. Independent replication is limited, so how far the findings extend to humans remains an open question.
Identity and purity are checked with standard peptide techniques. Reversed-phase high-performance liquid chromatography separates the main peak from closely related impurities and yields a percentage purity. Mass spectrometry confirms that the measured mass matches the theoretical value. Amino acid analysis offers an independent check on overall composition. These analytical methods characterize the material itself and reveal nothing about how it behaves in a living system.
In its common research form the peptide is supplied as a lyophilized powder. It dissolves readily in water and in typical aqueous buffers, which simplifies preparation of working solutions. Laboratories usually prepare small aliquots instead of one large volume. The dry material appears as a white to off-white solid with no distinctive odor. Bulk quantities are typically shipped in sealed vials.
Lyophilized material is generally kept cold, commonly at minus twenty degrees Celsius, and shielded from moisture and light. Solutions are less stable than the dry powder, so repeated freeze-thaw cycles are avoided by splitting the material into single-use portions. Published stability data for this particular peptide are limited, which means suggested hold times should be read as provisional. Long-term refrigeration of reconstituted solutions is not well supported by available evidence.
| Property | Value | Notes |
|---|---|---|
| Main study model | Rodents, rats and mice | Underpins most of the published data |
| Common routes in studies | Subcutaneous, intraperitoneal, oral | Varies with the experimental design |
| Common analytical method | Reversed-phase HPLC, LC-MS | Used for identity and purity checks |
| Human evidence base | Small | Few trials reported, with limited findings |
| Regulatory status | Varies by jurisdiction | Not an approved medicine in most places |
Most published findings come from rodent models, where the peptide has been examined in wound-healing, gastrointestinal-lesion, tendon, and vascular-injury preparations. A smaller number of early human studies have been reported, chiefly in inflammatory bowel conditions, but the public record is short and has not led to marketing approval in the United States or the European Union. Reviewers therefore classify the compound as investigational, and whether animal results carry over to people remains an open question rather than a settled one.
Outside laboratory supply channels, the peptide is sold as a research chemical, a category that carries no requirement to demonstrate purity, identity, or freedom from contamination. Because it is not an approved medicine, products labeled BPC-157 sit in a regulatory gap in many countries, and actual content may differ from the label. Sports organizations list it among prohibited substances, so its presence in an athlete's sample can produce a doping finding regardless of how the material was obtained.
BPC-157 is a synthetic peptide of fifteen amino acids, written as GEPPPGKPADDAGLV, whose sequence matches part of a larger protein identified in human gastric juice. That parent protein was described in stomach-secretion research, and the fifteen-residue fragment was named body protection compound, which gives the peptide its common label. Material used in experiments is produced by solid-phase peptide synthesis rather than extracted from tissue. The reported molecular weight is about 1419 daltons, and the chain contains several proline residues, a feature that appears in discussions of its resistance to enzymatic breakdown.
Proposed mechanisms include interaction with the nitric oxide system, modulation of growth factor signaling, and effects on blood vessel formation. None of these has been established as the primary mode of action, and some proposed pathways rest on indirect measurements. Whether the reported effects depend on a specific receptor has not been determined. Stability in gastric acid, unusual for a peptide of this size, is also reported in animal work, but the reason for it is not firmly established.
Published studies on BPC-157 are dominated by animal models. Commonly used endpoints include healing of surgically induced lesions in the stomach, tendon-to-bone attachment after transection, and recovery from experimentally induced vascular or intestinal damage. Many of these reports come from a small number of research groups, and the peptide is often described as acting across a wide range of tissue types. That breadth is itself a point of discussion, since one molecule influencing many unrelated systems is unusual.
Once dissolved, the material is considerably less stable than the dry solid. Aqueous solutions are usually kept cold and used within a short window, and neutral or mildly acidic buffers are preferred over strongly alkaline conditions. Freeze-thaw cycles promote aggregation and loss of material to container surfaces, so dividing a batch into single-use aliquots is standard. Adsorption to plastic and glass can lower the measured concentration, meaning solution strength may need rechecking before an experiment.
Identity and purity are established with complementary methods rather than one test. Reverse-phase high-performance liquid chromatography separates the main peak from deletion sequences and oxidized variants, and its area percentage is the usual purity figure. Mass spectrometry confirms the expected molecular mass and can flag truncations or modifications that chromatography alone might miss. Amino acid analysis and peptide mapping add sequence-level confirmation, while residual counter-ion and water content are measured separately.
10 September – As the newly discovered BA.2.86 COVID-19 variant (known unofficially as Pirola) continues to spread, Professor Rowland Kao, an infections expert from the University of Edinburgh, calls for lateral flow COVID tests to be made freely available again. 13 September – Alister Jack, the Secretary of State for Scotland, confirms the UK government will not block Scottish Government plans for a drug consumption room pilot scheme in Scotland. 19 September – The Scottish Government begins its legal challenge against Westminster over the UK government's decision to block the controversial Gender Recognition Reform (Scotland) Bill. 20 September – Elena Whitham, the Minister for Drugs and Alcohol Policy, announces plans to launch a consultation on raising the minimum price of alcohol in Scotland to 65p a unit. 21 September – Hunter Street Health Centre in the East End of Glasgow is earmarked as the site of the UK's first legal drugs consumption centre. 26 September – Data released by National Records of Scotland indicates life expectancy in Scotland has fallen for the third consecutive year, with the average age now 76.5 years for men and 80.7 years for women; the decrease from 2022 is three weeks for men and six weeks for women. 27 September – Glasgow's Integration Joint Board approves the UK's first official drugs consumption room for illegal drugs.
C4 (Colombia), a political party in Colombia C4, a social welfare non-profit entity organized under section 501(c)(4) of the U.S. Internal Revenue Code Churches Covered and Connected in Covenant, a religious association founded by Archbishop LeRoy Bailey Jr. Craiova Group, a cooperation project of four European states
Mimoun "Rocky" Kaabouni, who was nicknamed "The Moroccan Escobar", was born in Ben Taïeb, a village in the province of Nador. He grew up in Hoensbroek, in the Netherlands, where he and his brother owned a coffeeshop named Happy Days. While often visiting Amsterdam, he eventually started meeting big names within the Moroccan mafia with whom he maintained regular contact. Mimoun left the Netherlands for southern Spain and Romania, where he founded his own criminal organisation made up of Lithuanians and Colombians. Mimoun, who was already bringing in tons of cocaine through the ports of Antwerp, Rotterdam, Amsterdam, and Algeciras, wanted to create a new route in Romania through the port of Constanța. He is currently serving a 19-year prison sentence in Romania for a record seizure of 2.5 tons of cocaine (the biggest seizure of cocaine in the country's history). Mimoun was arrested in 2016 when he tried to leave Spain through the Málaga Airport after the seizure in Romania, which was worth €600 million. It was one of the largest drug seizures in Eastern European history.
=== Biodegradation === Some organisms are capable of metabolizing alkanes. The methane monooxygenases convert methane to methanol. For higher alkanes, cytochrome P450 convert alkanes to alcohols, which are then susceptible to degradation.
==== Mechanism of action ==== Nabilone weakly stimulates cannabinoid receptor 1(CBR1) and cannabinoid receptor 2 (CBR2) in the central nervous system. It reduces vomiting mainly by interacting with CBR1. Nabilone shares some similarity with tetrahydrocannabinol (THC) in terms of chemical structure, but nabilone is also considered to be twice as active as THC.
Sources: en.wikipedia.org
A number of Neanderthal fossils had been discovered before their antiquity was fully understood. The first Neanderthal remains—Engis 2 (a skull)—were discovered in 1829 by Dutch/Belgian prehistorian Philippe-Charles Schmerling in the Grottes d'Engis, Belgium. He concluded that these "poorly developed" human remains must have been buried at the same time and by the same causes as the co-existing remains of extinct animal species. In 1848, Gibraltar 1 from Forbes' Quarry was presented to the Gibraltar Scientific Society by their Secretary Lieutenant Edmund Henry Réné Flint, but was thought to be a modern human skull. In 1856, local schoolteacher Johann Carl Fuhlrott recognised bones from Kleine Feldhofer Grotte in Neander Valley—Neanderthal 1—as distinct from modern humans, and gave them to German anthropologist Hermann Schaaffhausen to study in 1857. It comprised the cranium, thigh bones, right arm, left humerus and ulna, left ilium (hip bone), part of the right shoulder blade, and pieces of the ribs.
Ginkgos have a conical crown in youth which becomes progressively broader and more irregular with age. They are large trees, normally reaching a height of 20–35 m (66–115 ft), with some specimens in China being over 40 m (130 ft). The tree has an angular crown and long, somewhat erratic branches, and is usually deep-rooted and resistant to wind and snow damage. Young trees are often tall and slender, and sparsely branched; the crown becomes broader as the tree ages. A combination of resistance to disease, insect-resistant wood, and the ability to form aerial roots and sprouts makes ginkgos durable, with some specimens estimated to be more than 3,500 years old.
== Metabolism == The kynurenine pathway of tryptophan catabolism leads to nicotinamide adenine dinucleotide and supplies the nicotinic acid component of that cofactor. In this pathway, quinolinic acid is produced spontaneously from the intermediate semialdehyde as its amine cyclises with the aldehyde, losing a molecule of water:
==== Nations ==== India: Randhir Jaiswal, the official spokesperson of the Ministry of External Affairs, expressed strong condemnation of the strikes and expressed support for Afghanistan's sovereignty and territorial integrity. Qatar: Qatari foreign minister Mohammed bin Abdulaziz Al Khulaifi discussed with Pakistani Foreign Minister Muhammad Ishaq Dar ways to reduce tension between Pakistan and Afghanistan, thereby strengthening security and stability in the region. Russia: The Russian government offered to mediate the situation and urged both nations to halt cross-border attacks. Saudi Arabia: Prince Faisal bin Farhan and officials in the Pakistani government discussed ways to reduce regional tensions during a phone call. United States: The White House stated that it will continue to monitor the situation closely and expressed support for Pakistan against the Taliban attacks. US president Donald Trump praised both Shehbaz Sharif and Asim Munir for fighting against Taliban forces. In addition, Bangladesh, China, Egypt, Iran, Iraq, Jordan, Malaysia, and Uzbekistan also called for a ceasefire to end hostilities and promoted dialogue to resolve border tensions.
Sources: en.wikipedia.org
Animal experiments form the bulk of the published record. Rodent models of tendon, ligament, bone, and gut injury are the most common designs. Controlled human trials are rare, which limits confidence in any clinical claim.
They are best described as working hypotheses. Supporting data come mainly from cell cultures and animal tissue, using markers such as growth factors and inflammatory signals. Confirmatory human studies have not been reported.
Status depends on the country. In some places it is treated as a research chemical available without a prescription, while elsewhere it falls under prescription or controlled rules. It holds no general marketing approval as a therapeutic product.
Dry powder is commonly held at minus twenty degrees Celsius, desiccated and away from light. Cold storage slows degradation of the lyophilized material.